Quality & Patient Safety

Pilot project to track adverse events related to blood transfusions

Patient Safety Monitor Alert, May 13, 2009

Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

Nine hospitals began taking part in a pilot program last week to track and analyze adverse events related to blood transfusions. The AABB, formerly known as the American Association of Blood Banks, is launching a national "hemovigilance" pilot program in conjunction with a larger U.S. Biovigilance Network. The larger project will track adverse events related to tissue, organ, and cell therapy transplantation using both governmental and nongovernmental agencies in a confidential manner.

There is currently no national system in place to track adverse events related to blood and blood transfusions. Data collected from such a system would prevent similar errors in the future.

To read more from the AABB, click here.



Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

Most Popular

Related Articles